Transparency Register Care gives much more insight into the financial relationships between pharmaceutical companies and health care providers than before. As a result, the number of reported relationships and the total amount thus incurred is increased dramatically in 2015, according to figures released today publishes the register.
In 2015, more than 14 thousand reported relationships; that’s over 70 percent more than added in 2014. Together, went to nearly 52 million, considerably more than the 38 million in 2014. That’s because even standing relationships with patient organizations listed since last year, and expenses for services and fees refresher courses for individual health care providers. There are also on a trial mentioned relationships between suppliers of medical devices and medical (on cardiology and orthopedic area).
In more than 10 thousand cases related to relationships between pharma and individual care. It involved in 35 percent to participation in advisory or act as speaker, 30 percent was in the framework of education, a quarter went to expenses.
The payments for non-WMO complicit research fall since last year outside the Code of the Scheme and are therefore not part of this register. In the Transparency Register press release states that Nefarma will announce within a few months itself
striking detail. The data contained in the registry will be deleted after three years, “for privacy purposes. The data is no longer accessible pocket in 2012.
The data will appear on 2015 from Monday to Transparantieregister.nl.
Sophie Broersen
Online published: april 25, 2016
There are no comments yet for this post. Do not see any comment form?
<- resourceInstances [Lnl.gx.webmanager.cms.integration.ResourceInstance; @ 4e45220 ->
Latest news! | Behind the news | newsletter | Date records
No comments:
Post a Comment